CC-100004 ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 84 | サルコイドーシス | 1 |
84. サルコイドーシス
臨床試験数 : 149 / 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00794274 (ClinicalTrials.gov) | November 2008 | 19/11/2008 | The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis | The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis | Sarcoidosis;Cutaneous Sarcoidosis | Drug: CC-100004 | University of Cincinnati | Celgene Corporation;Medical University of South Carolina | Completed | 18 Years | 80 Years | Both | 15 | Phase 2/Phase 3 | United States |